Q-omics provides the consensus-scored SMIM33 profile across patient tissues and cancer cell-line models. Additionally, SMIM33 RNA expression shows 11,917 significant protein co-abundance associations, with the highest sampling consensus in CCRCC.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for SMIM33 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with SMIM33 in patient tissues and cancer cell lines. In patient samples, SMIM33 shows the broadest associations at the RNA and protein expression levels, with CCRCC recurring as the lineage with the largest associated feature set. In cancer cell lines, SMIM33 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in BLOOD_Lymphoma.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Protein (mass-spec)	11,917	CCRCC (2807)	view →
Function (mass-spec)	596	CCRCC (132)	view →

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	4,842	BLOOD_Lymphoma (1814)	view →
Function (RNA)	1,730	BLOOD_Lymphoma (817)	view →